CareDx (CDNA) Tops Q4 EPS by 11c, provides guidance

CareDx (NASDAQ: CDNA) reported Q4 EPS of $0.12, $0.11 better than the analyst estimate of $0.01. Revenue for the quarter came in at $108 million versus the consensus estimate of $102.18 million.

GUIDANCE:

CareDx sees FY2026 revenue of $420-444 million, versus the consensus of $417.7 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Trump Bought At Least $100,001 In Palantir Shares, Disclosure Shows - Bloomberg
• Anthropic: US Lifts Export Controls On Claude Fable 5, Mythos 5
• Wolfe Research Upgrades FOX Corp. (FOXA) to Outperform